Cargando…
The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan
Background: There are no uniform guidelines on low-dose computed tomography (LDCT) follow-up in lung cancer screening. Few studies have analyzed the incidental abnormalities and role of tumor markers in lung cancer screening. The purpose of this study was to investigate the diagnostic performance of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579303/ https://www.ncbi.nlm.nih.gov/pubmed/34790062 http://dx.doi.org/10.7150/ijms.64648 |
_version_ | 1784596413635624960 |
---|---|
author | Wu, Chih-Wei Ku, Yen-Te Huang, Chun-Yao Hsieh, Po-Chun Lim, Kun-Eng Tzeng, I-Shiang Lan, Chou-Chin Wu, Yao-Kuang Hsu, Yi-Chiung |
author_facet | Wu, Chih-Wei Ku, Yen-Te Huang, Chun-Yao Hsieh, Po-Chun Lim, Kun-Eng Tzeng, I-Shiang Lan, Chou-Chin Wu, Yao-Kuang Hsu, Yi-Chiung |
author_sort | Wu, Chih-Wei |
collection | PubMed |
description | Background: There are no uniform guidelines on low-dose computed tomography (LDCT) follow-up in lung cancer screening. Few studies have analyzed the incidental abnormalities and role of tumor markers in lung cancer screening. The purpose of this study was to investigate the diagnostic performance of LDCT, optimal follow-up duration, incidental findings, and role of tumor markers in diagnosing lung cancer. Methods: We retrospectively analyzed subjects who underwent their first LDCT in Taipei Tzu Chi Hospital between September 1, 2015, and August 31, 2016. All chest CT scans until August 31, 2020, were recorded. A non-calcified nodule with a diameter ≥2 mm on LDCT was defined as a positive result. We extracted the data, including possible risk factors of lung cancer and follow-up outcomes. Results: A total of 1502 subjects were recruited. Of the 38 subjects who underwent biopsy, 31 had confirmed lung cancer. Lung cancer in all patients was diagnosed within 4 years. Univariate logistic regression analysis revealed that a family history of lung cancer in first-degree relatives and abnormal serum carcinoembryonic antigen (CEA) levels were the significant risk factors for lung cancer. A cumulative lung cancer incidence of 54.7 patients per 1000 person-years was determined solely via radiological follow-up. In total, 271 (18%) subjects exhibited incidental findings on baseline LDCT. Conclusion: The overall lung cancer detection rate in this study was 2.1% in the 5-year study period. A family history of lung cancer and abnormal serum CEA levels are important risk factors for lung cancer. A minimum of 4-year follow-up is required to track suspicious nodules. A purely radiological follow-up detects a high incidence of lung cancer. |
format | Online Article Text |
id | pubmed-8579303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-85793032021-11-16 The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan Wu, Chih-Wei Ku, Yen-Te Huang, Chun-Yao Hsieh, Po-Chun Lim, Kun-Eng Tzeng, I-Shiang Lan, Chou-Chin Wu, Yao-Kuang Hsu, Yi-Chiung Int J Med Sci Research Paper Background: There are no uniform guidelines on low-dose computed tomography (LDCT) follow-up in lung cancer screening. Few studies have analyzed the incidental abnormalities and role of tumor markers in lung cancer screening. The purpose of this study was to investigate the diagnostic performance of LDCT, optimal follow-up duration, incidental findings, and role of tumor markers in diagnosing lung cancer. Methods: We retrospectively analyzed subjects who underwent their first LDCT in Taipei Tzu Chi Hospital between September 1, 2015, and August 31, 2016. All chest CT scans until August 31, 2020, were recorded. A non-calcified nodule with a diameter ≥2 mm on LDCT was defined as a positive result. We extracted the data, including possible risk factors of lung cancer and follow-up outcomes. Results: A total of 1502 subjects were recruited. Of the 38 subjects who underwent biopsy, 31 had confirmed lung cancer. Lung cancer in all patients was diagnosed within 4 years. Univariate logistic regression analysis revealed that a family history of lung cancer in first-degree relatives and abnormal serum carcinoembryonic antigen (CEA) levels were the significant risk factors for lung cancer. A cumulative lung cancer incidence of 54.7 patients per 1000 person-years was determined solely via radiological follow-up. In total, 271 (18%) subjects exhibited incidental findings on baseline LDCT. Conclusion: The overall lung cancer detection rate in this study was 2.1% in the 5-year study period. A family history of lung cancer and abnormal serum CEA levels are important risk factors for lung cancer. A minimum of 4-year follow-up is required to track suspicious nodules. A purely radiological follow-up detects a high incidence of lung cancer. Ivyspring International Publisher 2021-10-31 /pmc/articles/PMC8579303/ /pubmed/34790062 http://dx.doi.org/10.7150/ijms.64648 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Wu, Chih-Wei Ku, Yen-Te Huang, Chun-Yao Hsieh, Po-Chun Lim, Kun-Eng Tzeng, I-Shiang Lan, Chou-Chin Wu, Yao-Kuang Hsu, Yi-Chiung The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan |
title | The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan |
title_full | The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan |
title_fullStr | The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan |
title_full_unstemmed | The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan |
title_short | The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan |
title_sort | built study: a single-center 5-year experience of lung cancer screening in taiwan |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579303/ https://www.ncbi.nlm.nih.gov/pubmed/34790062 http://dx.doi.org/10.7150/ijms.64648 |
work_keys_str_mv | AT wuchihwei thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT kuyente thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT huangchunyao thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT hsiehpochun thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT limkuneng thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT tzengishiang thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT lanchouchin thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT wuyaokuang thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT hsuyichiung thebuiltstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT wuchihwei builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT kuyente builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT huangchunyao builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT hsiehpochun builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT limkuneng builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT tzengishiang builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT lanchouchin builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT wuyaokuang builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan AT hsuyichiung builtstudyasinglecenter5yearexperienceoflungcancerscreeningintaiwan |